So you think that if a new big player arrived who had only just discovered INSM - perhaps because INSM was one of the "eight biotech growth stocks" named by the Wedbush analyst last week - let it be known to the major shareholders that he wanted to buy a million shares, those shareholders between them would be prepared to sell him a million shares for less than $7 - at a stage when the share price will almost certainly rocket to many multiples of $7 provided the nine-month dog toxicity study initiated over nine months ago went well?
My gut feeling after seeing the apparent drop in GOOG by 48% is that this was some sort of Nasdaq glitch. But if somebody did indeed purchase a serious amount of INSM on Friday in a private deal I would consider it "ridiculous" to suggest that a serious amount of shares would be available BELOW $7.
So much for those really exciting "dark pool" trades (whatever the the h*ll they are) and new big players and all the ifs and ands and but. Remember some people are here telling tales 24/7. They'll even give you reasons why they share price falling is a good thing. Beware!